Patents Examined by Alan Diamond
  • Patent number: RE46187
    Abstract: The invention provides a positive electrode material and a battery using the same which can achieve a higher discharge voltage and which can obtain excellent charge-and-discharge properties, without reducing the capacity. A positive electrode (12) and a negative electrode (14) are configured through a separator (15) in between. The positive electrode (12) contains a compound expressed by a general formula Li1+xMnyFezPO4 (wherein x, y and z are values within ranges of 0<x<0.1, 0.5<y<0.95, and 0.9<y+z?1, respectively). According to the compound, the higher discharge voltage can be obtained due to Mn, the Jahn Teller effect of Mn3+ can be attenuated and furthermore distortion of the crystal structure and the reduction of the capacity can be inhibited due to Fe and the excess Li.
    Type: Grant
    Filed: April 11, 2008
    Date of Patent: October 25, 2016
    Assignee: SONY CORPORATION
    Inventor: Guohua Li
  • Patent number: RE46276
    Abstract: Triazolo[4,5-d]pyrimidine compounds, their use as medicaments, compositions containing them and processes for their preparation. The compounds of the invention have the formula (I) as follows: wherein R, X and R1 through R3 are as defined in the specification.
    Type: Grant
    Filed: December 21, 2015
    Date of Patent: January 17, 2017
    Assignee: AstraZeneca UK Limited
    Inventors: David Hardem, Anthony Ingall, Brian Springthorpe, Paul Willis, Simon Guile
  • Patent number: RE46315
    Abstract: A method and system of forming large-diameter SiC single crystals suitable for fabricating high crystal quality SiC substrates of 100, 125, 150 and 200 mm in diameter are described. The SiC single crystals are grown by a seeded sublimation technique in the presence of a shallow radial temperature gradient. During SiC sublimation growth, a flux of SiC bearing vapors filtered from carbon particulates is substantially restricted to a central area of the surface of the seed crystal by a separation plate disposed between the seed crystal and a source of the SiC bearing vapors. The separation plate includes a first, substantially vapor-permeable part surrounded by a second, substantially non vapor-permeable part. The grown crystals have a flat or slightly convex growth interface. Large-diameter SiC wafers fabricated from the grown crystals exhibit low lattice curvature and low densities of crystal defects, such as stacking faults, inclusions, micropipes and dislocations.
    Type: Grant
    Filed: October 6, 2014
    Date of Patent: February 21, 2017
    Assignee: II-VI Incorporated
    Inventors: Ilya Zwieback, Thomas E. Anderson, Andrew E. Souzis, Gary E. Ruland, Avinash K. Gupta, Varatharajan Rengarajan, Ping Wu, Xueping Xu
  • Patent number: RE46365
    Abstract: A novel compound which is useful as an agent for treating and/or preventing emesis, vomiting and/or constipation. A compound represented by the formula (I): wherein R1 and R2 are each independently hydrogen, optionally substituted lower alkyl, optionally substituted lower alkenyl, optionally substituted cycloalkyl, optionally substituted aryl etc., R3 is hydrogen, hydroxy, optionally substituted lower alkyl, optionally substituted lower alkenyl, optionally substituted lower alkynyl, optionally substituted lower alkoxy etc., R4 is hydrogen or lower alkyl, R5 is hydrogen, lower alkyl, cycloalkyl lower alkyl or lower alkenyl, or a pharmaceutically acceptably salt, or a solvate thereof is provided.
    Type: Grant
    Filed: March 8, 2016
    Date of Patent: April 11, 2017
    Assignee: Shionogi & Co., Ltd.
    Inventors: Masanao Inagaki, Shin-ichiro Hara, Nobuhiro Haga, Yoshinori Tamura, Yoshihisa Goto, Tsuyoshi Hasegawa
  • Patent number: RE46375
    Abstract: A novel compound which is useful as an agent for treating and/or preventing emesis, vomiting and/or constipation. A compound represented by the formula (I): wherein R1 and R2 are each independently hydrogen, optionally substituted lower alkyl, optionally substituted lower alkenyl, optionally substituted cycloalkyl, optionally substituted aryl etc., R3 is hydrogen, hydroxy, optionally substituted lower alkyl, optionally substituted lower alkenyl, optionally substituted lower alkynyl, optionally substituted lower alkoxy etc., R4 is hydrogen or lower alkyl, R5 is hydrogen, lower alkyl, cycloalkyl lower alkyl or lower alkenyl, or a pharmaceutically acceptably acceptable salt, or a solvate thereof is provided.
    Type: Grant
    Filed: March 8, 2016
    Date of Patent: April 25, 2017
    Assignee: Shionogi & Co., Ltd.
    Inventors: Masanao Inagaki, Shin-ichiro Hara, Nobuhiro Haga, Yoshinori Tamura, Yoshihisa Goto, Tsuyoshi Hasegawa
  • Patent number: RE46417
    Abstract: A compound according to formula (I) wherein: © is a phenyl ring, a C4 to C9 heteroaromatic compound containing one or more heteroatoms, or a naphthalenyl, 5,6,7,8-tetrahydronaphthalenyl or biphenyl group; which shows high affinity for muscarinic M3 receptors (Hm3).
    Type: Grant
    Filed: February 9, 2016
    Date of Patent: May 30, 2017
    Assignee: Almirall, S.A.
    Inventors: Dolors Fernandez Forner, Maria Prat Quiñones, Maria Antonia Buil Albero
  • Patent number: RE46511
    Abstract: The present invention relates to a novel fused pyrimidine derivative having an inhibitory activity for tyrosine kinases, and a pharmaceutical composition for preventing or treating cancers, tumors, inflammatory diseases, autoimmune diseases, or immunologically mediated diseases comprising same as an active ingredient.
    Type: Grant
    Filed: April 14, 2016
    Date of Patent: August 15, 2017
    Assignee: HANMI SCIENCE CO., LTD.
    Inventors: Mi Young Cha, Seok Jong Kang, Mi Ra Kim, Ju Yeon Lee, Ji Young Jeon, Myoung Gi Jo, Eun Joo Kwak, Kwang Ok Lee, Tae Hee Ha, Kwee Hyun Suh, Maeng Sup Kim
  • Patent number: RE46515
    Abstract: A solar cell is discussed. The solar cell includes a substrate of a first conductive type, an emitter region of a second conductive type opposite the first conductive type that is positioned on the substrate, a first field region of the first conductive type that is positioned on the substrate to be separated from the emitter region, a first electrode electrically connected to the emitter region, a second electrode electrically connected to the first field region, and an insulating region positioned on at least one of the emitter region and the first field region.
    Type: Grant
    Filed: September 2, 2015
    Date of Patent: August 15, 2017
    Assignee: LG ELECTRONICS INC.
    Inventors: Kwangsun Ji, Heonmin Lee, Hojung Syn, Wonseok Choi, Junghoon Choi, Hyunjin Yang
  • Patent number: RE46559
    Abstract: In flow cytometry, particles (2) can be distinguished between populations (8) by combining n-dimensional parameter data, which may be derived from signal data from a particle, to mathematically achieve numerical results representative of an alteration (48). An alteration may include a rotational alteration, a scaled alteration, or perhaps even a translational alteration. Alterations may enhance separation of data points which may provide real-time classification (49) of signal data corresponding to individual particles into one of at least two populations.
    Type: Grant
    Filed: February 21, 2017
    Date of Patent: September 26, 2017
    Assignee: Beckman Coulter, Inc.
    Inventors: George C. Malachowski, Paul Barclay Purcell, Edward Allan Stanton, Kenneth Michael Evans
  • Patent number: RE46667
    Abstract: The invention provides a positive electrode material and a battery using the same which can achieve a higher discharge voltage and which can obtain excellent charge-and-discharge properties, without reducing the capacity. A positive electrode (12) and a negative electrode (14) are configured through a separator (15) in between. The positive electrode (12) contains a compound expressed by a general formula Li1+xMnyFezPO4 (wherein x, y and z are values within ranges of 0<x<0.1, 0.5<y<0.95, and 0.9<y+z?1, respectively). According to the compound, the higher discharge voltage can be obtained due to Mn, the Jahn Teller effect of Mn3+ can be attenuated and furthermore distortion of the crystal structure and the reduction of the capacity can be inhibited due to Fe and the excess Li.
    Type: Grant
    Filed: July 29, 2016
    Date of Patent: January 9, 2018
    Assignee: SONY CORPORATION
    Inventor: Guohua Li
  • Patent number: RE46688
    Abstract: An object of the present invention is to provide a curable composition that can be used as sealing materials, adhesives, and the like, has excellent curing properties, and gives a cured product excellent in elongation properties. The object can be attained by means of a curable composition comprising: a reactive silyl group-containing polyether polymer (A) that contains a reactive silyl group with high activity (e.g., (ClCH2)(CH3O)2Si—, (CH3OCH2)(CH3O)2Si—, or CH3(CH3O)2Si—CH2—NH—C(?O)—); and a reactive silyl group-containing polyether polymer (B) that contains a reactive silyl group (e.g., CH3(CH3O)2Si— or (CH3O)3Si—) different from that mentioned above and/or a (meth)acrylic polymer (C) containing a reactive silyl group that is not particularly limited.
    Type: Grant
    Filed: December 2, 2015
    Date of Patent: January 30, 2018
    Assignee: KANEKA CORPORATION
    Inventors: Kiyoshi Miyafuji, Toyohisa Fujimoto, Katsuyu Wakabayashi, Toshihiko Okamoto
  • Patent number: RE46763
    Abstract: Described is a liquid crystal composition which satisfies at least one of such characteristics as high upper limit temperature of the nematic phase, low lower limit temperature of the nematic phase, low viscosity, adequate optical anisotropy, large negative dielectric anisotropy, high resistivity, high stability to ultraviolet light and high stability to heat, or which has an adequate balance between at least two of the above-mentioned characteristics. Also described is an AM element having a short response time, high voltage holding ratio, high contrast ratio, long life and the like. The liquid crystal composition contains a specific compound having a large negative dielectric anisotropy and a low lower limit temperature as a first component, a specific compound having a low viscosity or a high upper limit temperature as a second component, and a specific compound having a polymerizable group as a third component. The AM element contains the composition.
    Type: Grant
    Filed: October 9, 2015
    Date of Patent: March 27, 2018
    Assignees: JNC CORPORATION, JNC PETROCHEMICAL CORPORATION
    Inventor: Masayuki Saito
  • Patent number: RE46817
    Abstract: Methods, compositions and articles of manufacture for assaying a sample for a target polynucleotide are provided. A sample suspected of containing the target polynucleotide is contacted with a polycationic multichromophore and a sensor polynucleotide complementary to the target polynucleotide. The sensor polynucleotide comprises a signaling chromophore to receive energy from the excited multichromophore and increase emission in the presence of the target polynucleotide. The methods can be used in multiplex form. Kits comprising reagents for performing such methods are also provided.
    Type: Grant
    Filed: March 29, 2017
    Date of Patent: May 1, 2018
    Assignee: The Regents of the University of California
    Inventors: Guillermo C. Bazan, Brent S. Gaylord, Shu Wang
  • Patent number: RE46965
    Abstract: The present invention provides macrocyclic compounds, synthesis of the same and intermediates thereto. Such compounds, and compositions thereof, are useful for treating or preventing proliferative disorders Formula (F-4).
    Type: Grant
    Filed: June 24, 2013
    Date of Patent: July 24, 2018
    Assignee: Eisai R&D Management Co., Ltd.
    Inventors: Brian Austad, Charles E. Chase, Francis G. Fang, Trevor Calkins, Bryan M. Lewis
  • Patent number: RE46974
    Abstract: An organic electroluminescence device 1 includes: an anode 3, a cathode 4 opposed to the anode 3 and an emitting layer 5 provided between the anode 3 and the cathode 4. The emitting layer 5 contains first and second host materials and a luminescent material. The first host material has a partial structure represented by at least one of the following formulae (1) and (2) while the second host material has a partial structure represented by the following formula (3). Az represents a substituted or unsubstituted aromatic heterocyclic group containing a nitrogen-containing six-membered ring. WCN is an aromatic hydrocarbon group substituted by at least one cyano group (CN) or an aromatic heterocyclic group substituted by at least one cyano group (CN). Ar1 is a substituted or unsubstituted aromatic hydrocarbon group or a substituted or unsubstituted aromatic heterocyclic group, but is not an aromatic heterocyclic group containing a nitrogen-containing six-membered ring.
    Type: Grant
    Filed: December 16, 2016
    Date of Patent: July 31, 2018
    Assignee: IDEMITSU KOSAN CO., LTD.
    Inventors: Kazuki Nishimura, Tetsuya Inoue, Yumiko Mizuki, Nobuhiro Yabunouchi, Mitsuru Eida
  • Patent number: RE46999
    Abstract: Acetic acid is produced while inhibiting increased concentrations of hydrogen iodide and acetic acid in an acetaldehyde distillation column.
    Type: Grant
    Filed: July 31, 2017
    Date of Patent: August 21, 2018
    Assignee: DAICEL CORPORATION
    Inventors: Masahiko Shimizu, Ryuji Saito, Hiroyuki Miura
  • Patent number: RE47072
    Abstract: An insulated gate turn-off (IGTO) device, formed as a die, has a layered structure including a p+ layer (e.g., a substrate), an n? epi layer, a p-well, vertical insulated gate regions formed in the p-well, and n+ regions between the gate regions, so that vertical NPN and PNP transistors are formed. The device is formed of a matrix of cells. To turn the device on, a positive voltage is applied to the gate, referenced to the cathode. The cells further contain a vertical p-channel MOSFET, for shorting the base of the NPN transistor to its emitter, to turn the NPN transistor off when the p-channel MOSFET is turned on by a slight negative voltage applied to the gate. This allows the IGTO device to be more easily turned off while in a latch-up condition, when the device is acting like a thyristor.
    Type: Grant
    Filed: August 14, 2017
    Date of Patent: October 2, 2018
    Assignee: Pakal Technologies, LLC
    Inventors: Vladimir Rodov, Hidenori Akiyama, Richard A. Blanchard, Woytek Tworzydlo
  • Patent number: RE47080
    Abstract: A system for nucleic acid amplification of a sample comprises partitioning the sample into partitioned sections and performing PCR on the partitioned sections of the sample. Another embodiment of the invention provides a system for nucleic acid amplification and detection of a sample comprising partitioning the sample into partitioned sections, performing PCR on the partitioned sections of the sample, and detecting and analyzing the partitioned sections of the sample.
    Type: Grant
    Filed: January 31, 2017
    Date of Patent: October 9, 2018
    Assignee: Lawrence Livermore National Security, LLC
    Inventors: Brian L. Anderson, Bill W. Colston, Christopher J. Elkin
  • Patent number: RE47157
    Abstract: The present invention provides systems, articles, and methods for discriminating electromagnetic radiation based upon the angle of incidence of the electromagnetic radiation. In some cases, the materials and systems described herein can be capable of inhibiting reflection of electromagnetic radiation (e.g., the materials and systems can be capable of transmitting and/or absorbing electromagnetic radiation) within a given range of angles of incidence at a first incident surface, while substantially reflecting electromagnetic radiation outside the range of angles of incidence at a second incident surface (which can be the same as or different from the first incident surface). A photonic material comprising a plurality of periodically occurring separate domains can be used, in some cases, to selectively transmit and/or selectively absorb one portion of incoming electromagnetic radiation while reflecting another portion of incoming electromagnetic radiation, based upon the angle of incidence.
    Type: Grant
    Filed: June 12, 2017
    Date of Patent: December 11, 2018
    Assignee: Massachusetts Institute of Technology
    Inventors: Rafif E. Hamam, Peter Bermel, Ivan Celanovic, Marin Soljacic, Adrian Y. X. Yeng, Michael Ghebrebrhan, John D. Joannopoulos
  • Patent number: RE47193
    Abstract: Embodiments of the disclosure relate to selectively substituted quinoline compounds that act as antagonists or inhibitors for Toll-like receptors 7 and/or 8, and their use in pharmaceutical compositions effective for treatment of systemic lupus erythematosus (SLE) and lupus nephritis.
    Type: Grant
    Filed: August 4, 2017
    Date of Patent: January 8, 2019
    Assignee: Eisai R&D Management Co., Ltd.
    Inventors: J. Eric Carlson, Hans Hansen, Lynn Hawkins, Sally Ishizaka, Matthew Mackey, Shawn Schiller, Chikako Ogawa, Heather Davis, Atsushi Endo